Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Enterprise Value: 2009-2025

Historic Enterprise Value for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $3.0 billion.

  • Prestige Consumer Healthcare's Enterprise Value fell 16.18% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 21.13%. This contributed to the annual value of $4.2 billion for FY2025, which is 17.01% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Enterprise Value stood at $3.0 billion for Q3 2025, which was down 22.45% from $3.8 billion recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Enterprise Value high stood at $4.2 billion for Q1 2025, and its period low was $2.2 billion during Q1 2021.
  • Its 3-year average for Enterprise Value is $3.4 billion, with a median of $3.4 billion in 2024.
  • Its Enterprise Value has fluctuated over the past 5 years, first spiked by 79.10% in 2021, then dropped by 16.18% in 2025.
  • Quarterly analysis of 5 years shows Prestige Consumer Healthcare's Enterprise Value stood at $3.0 billion in 2021, then decreased by 0.13% to $3.0 billion in 2022, then decreased by 1.32% to $3.0 billion in 2023, then increased by 28.01% to $3.8 billion in 2024, then declined by 16.18% to $3.0 billion in 2025.
  • Its Enterprise Value stands at $3.0 billion for Q3 2025, versus $3.8 billion for Q2 2025 and $4.2 billion for Q1 2025.